Home › Literature › The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

Cite as: De Vuyst, Geert (2 December 2022) The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration. Geert De Vuyst. https://geertdevuyst.be/en/publication/2007-ashton-the-cannabinoid-cb2-receptor-as-a-target-for-inflammation-dependent-neurodegeneration/

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration

Article English Educated

TitleThe Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent NeurodegenerationAuthor(s)Ashton, J., & Glass, M.JournalCurrent NeuropharmacologyVolume5Issue number2Year of publication2007Pages73-80DOIhttps://doi.org/10.2174/15701 ... PublisherBentham Science Publishers Ltd.Cite asAshton, J., & Glass, M. (2007). The Cannabinoid CB2 Receptor as a Target for Inflammation‑Dependent Neurodegeneration. Current Neuropharmacology, 5(2), 73–80. https://doi.org/10.2174/157015907780866884